Display options
Cite
Rao PN, Deo DD, Marchioni MA, et al. Structural and Functional Characterization of Deceased Donor Stem Cells: A Viable Alternative to Living Donor Stem Cells. Stem Cells Int. 2019;2019:5841587doi: 10.1155/2019/5841587.
Rao, P. N., Deo, D. D., Marchioni, M. A., Taghizadeh, R. R., Cetrulo, K., Sawczak, S., & Myrick, J. (2019). Structural and Functional Characterization of Deceased Donor Stem Cells: A Viable Alternative to Living Donor Stem Cells. Stem cells international, 20195841587. https://doi.org/10.1155/2019/5841587
Rao, Prakash N, et al. "Structural and Functional Characterization of Deceased Donor Stem Cells: A Viable Alternative to Living Donor Stem Cells." Stem cells international vol. 2019 (2019): 5841587. doi: https://doi.org/10.1155/2019/5841587
Rao PN, Deo DD, Marchioni MA, Taghizadeh RR, Cetrulo K, Sawczak S, Myrick J. Structural and Functional Characterization of Deceased Donor Stem Cells: A Viable Alternative to Living Donor Stem Cells. Stem Cells Int. 2019 Nov 25;2019:5841587. doi: 10.1155/2019/5841587. eCollection 2019. PMID: 31885618; PMCID: PMC6899284.
Copy Download .nbib Format: NLM
Share it on

Stem Cells Int. 2019 Nov 25;2019:5841587. doi: 10.1155/2019/5841587. eCollection 2019.

Structural and Functional Characterization of Deceased Donor Stem Cells: A Viable Alternative to Living Donor Stem Cells.

Stem cells international

Prakash N Rao, Dayanand D Deo, Misty A Marchioni, Rouzbeh R Taghizadeh, Kyle Cetrulo, Sharyn Sawczak, Jacob Myrick

Affiliations

  1. NJ Sharing Network, New Providence, NJ, USA.
  2. AuxoCell Laboratories, Inc., Cambridge, MA, USA.

PMID: 31885618 PMCID: PMC6899284 DOI: 10.1155/2019/5841587

Abstract

Stem cells can be isolated from various human tissues including bone marrow (BM) and adipose tissue (AT). Our study outlines a process to isolate adult stem cells from deceased donors. We have shown that cell counts obtained from deceased donor BM were within established living donor parameters. Evaluation of demographic information exhibited a higher percentage of hematopoietic stem cells (HSC) in males versus females, as well as a higher percentage of HSC in the age bracket of 25 years and under. For the first time, we show that deceased donor femur BM grew cell colonies. Our introduction of new technology for nonenzymatic AT processing significantly increased cell recovery over the traditional enzymatic processing method. Cell counts from the deceased donor AT exceeded living donor parameters. Furthermore, our data illustrated that AT from female donors yielded a much higher number of total nucleated cells (TNC) than males. Together, our data demonstrates that our approach to isolate stem cells from deceased donors could be a routine practice to provide a viable alternative to living donor stem cells. This will offer increased accessibility for patients awaiting stem cell therapies.

Copyright © 2019 Prakash N. Rao et al.

Conflict of interest statement

There are no conflicts of interest for the following authors: Prakash N. Rao, Dayanand D. Deo, Misty A. Marchioni, Sharyn Sawczak, and Jacob Myrick. Authors Kyle Cetrulo and Rouzbeh R. Taghizadeh are

References

  1. Cytotherapy. 2009;11(6):706-15 - PubMed
  2. Exp Neurol. 1999 Apr;156(2):430-3 - PubMed
  3. Biotechniques. 1995 Dec;19(6):942-5 - PubMed
  4. Transfus Med. 2010 Jun;20(3):169-77 - PubMed
  5. Int J Obes Relat Metab Disord. 2000 Nov;24 Suppl 4:S41-4 - PubMed
  6. Bone Marrow Transplant. 2008 Oct;42(7):443-7 - PubMed
  7. Biotechnol Lett. 2014 Apr;36(4):693-702 - PubMed
  8. Nat Med. 1996 Sep;2(9):1011-6 - PubMed
  9. Vox Sang. 2010 Apr;98(3 Pt 1):e276-83 - PubMed
  10. Trends Biotechnol. 2006 Apr;24(4):150-4 - PubMed
  11. Biologicals. 2016 Jan;44(1):12-8 - PubMed
  12. Plast Reconstr Surg. 2010 Dec;126(6):1911-23 - PubMed
  13. Transfusion. 2005 Apr;45(4):613-21 - PubMed
  14. Biomedicines. 2014 Feb 26;2(1):50-79 - PubMed
  15. Expert Opin Biol Ther. 2003 Aug;3(5):705-13 - PubMed
  16. Tissue Eng Part A. 2012 Jul;18(13-14):1313-21 - PubMed
  17. Tissue Eng. 2001 Apr;7(2):211-28 - PubMed
  18. Cytotherapy. 2004;6(1):7-14 - PubMed
  19. J Cell Physiol. 2006 Jul;208(1):64-76 - PubMed
  20. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9857-60 - PubMed
  21. Mol Biol Cell. 2005 Mar;16(3):1131-41 - PubMed
  22. J Transl Med. 2016 May 20;14(1):145 - PubMed
  23. Cell Transplant. 2003;12(1):83-90 - PubMed
  24. Cytotherapy. 2013 Jun;15(6):641-8 - PubMed
  25. Mech Ageing Dev. 2008 Mar;129(3):163-73 - PubMed
  26. Aesthetic Plast Surg. 1984;8(2):75-83 - PubMed
  27. Mol Med. 2008 Jul-Aug;14(7-8):493-501 - PubMed
  28. Blood. 1961 Jan;17:97-108 - PubMed
  29. Placenta. 2011 Oct;32 Suppl 4:S311-5 - PubMed
  30. Adv Wound Care (New Rochelle). 2014 Jan 1;3(1):38-45 - PubMed
  31. Clin Immunol Immunopathol. 1994 Jan;70(1):10-8 - PubMed
  32. Cytometry A. 2013 Jan;83(1):134-40 - PubMed
  33. Plast Reconstr Surg. 2014 Jun;133(6):1406-9 - PubMed
  34. Cytometry A. 2010 Jan;77(1):22-30 - PubMed
  35. Cytotherapy. 2006;8(4):315-7 - PubMed
  36. Br J Haematol. 2005 Apr;129(1):118-29 - PubMed
  37. Stem Cells Int. 2012;2012:461718 - PubMed
  38. Cell Mol Biol Lett. 2013 Dec;18(4):479-93 - PubMed
  39. Cell Tissue Res. 2008 Jun;332(3):415-26 - PubMed
  40. Stem Cells Int. 2017;2017:5173732 - PubMed
  41. Science. 1999 Apr 2;284(5411):143-7 - PubMed
  42. Hematology. 2004 Jun;9(3):159-63 - PubMed
  43. Cytotherapy. 2003;5(5):362-9 - PubMed
  44. Cell Transplant. 2018 Jan;27(1):181-193 - PubMed
  45. Blood. 1999 May 15;93(10):3294-301 - PubMed
  46. Cytotherapy. 2012 Jan;14(1):104-13 - PubMed
  47. Stem Cells Int. 2012;2012:812693 - PubMed
  48. Eur J Med Res. 2017 May 19;22(1):17 - PubMed
  49. ANZ J Surg. 2009 Apr;79(4):235-44 - PubMed
  50. Chimerism. 2011 Jul;2(3):86-7 - PubMed
  51. Transplant Proc. 1994 Dec;26(6):3377-8 - PubMed
  52. Immunity. 2001 Apr;14(4):425-36 - PubMed
  53. Exp Aging Res. 2010 Jul;36(3):359-70 - PubMed
  54. J Cell Physiol. 2001 Oct;189(1):54-63 - PubMed
  55. Artif Organs. 2010 Jul;34(7):594-9 - PubMed
  56. J Neurosci Res. 2003 Nov 15;74(4):533-40 - PubMed

Publication Types